[Recent developments in the field of fibrinolytics and anticoagulants].
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D003374:Coumarins / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006023:Glycoproteins / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008970:Molecular Weight; D010960:Plasminogen Activators / Q000627:therapeutic use; D011486:Protein C; D013923:Thromboembolism / Q000097:blood / Q000188:drug therapy*
D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D006023:Glycoproteins; D011486:Protein C; D006493:Heparin; D010960:Plasminogen Activators
Neuere Entwicklungen auf dem Gebiet der Fibrinolytika und Antikoagulantien.